DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,013,838 | +77.3% | 12,148 | +71.5% | 0.45% | +62.6% |
| Q2 2023 | $1,700,151 | +4.8% | 7,084 | +10.0% | 0.28% | -28.7% |
| Q1 2023 | $1,622,692 | -3.5% | 6,438 | +1.6% | 0.39% | -12.8% |
| Q4 2022 | $1,681,371 | +11.1% | 6,335 | +8.1% | 0.45% | -2.0% |
| Q3 2022 | $1,514,000 | -4.5% | 5,863 | -6.2% | 0.46% | -1.3% |
| Q2 2022 | $1,585,000 | -13.1% | 6,253 | +0.6% | 0.46% | -12.5% |
| Q1 2022 | $1,823,000 | -38.8% | 6,216 | -31.3% | 0.53% | -13.0% |
| Q4 2021 | $2,977,000 | +15.1% | 9,047 | +6.5% | 0.61% | +8.0% |
| Q3 2021 | $2,586,000 | +10.7% | 8,495 | -2.4% | 0.56% | +15.9% |
| Q2 2021 | $2,335,000 | +41.0% | 8,704 | +18.3% | 0.48% | +29.3% |
| Q1 2021 | $1,656,000 | +13.1% | 7,358 | +11.7% | 0.38% | -4.6% |
| Q4 2020 | $1,464,000 | +32.0% | 6,590 | +27.9% | 0.39% | -15.5% |
| Q3 2020 | $1,109,000 | +208.9% | 5,151 | +153.9% | 0.46% | +117.3% |
| Q2 2020 | $359,000 | – | 2,029 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |